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Previous work in our laboratory (Montague, J., Gaido,
M., Frye, C., and Cidlowski, J. (1994) J. Biol. Chem. 269,
18877–18880) has shown that human recombinant cyclo-
philins A, B, and C have sequence homology with the
apoptotic nuclease NUC18 and that denatured cyclophi-
lins can degrade DNA. We have now evaluated the nu-
cleolytic activity of recombinant cyclophilins under na-
tive conditions. We show that nuclease activity inherent
to cyclophilins is distinct from cis-trans-peptidylprolyl
isomerase activity and is similar to that described for
apoptotic nucleases. Cyclophilin nucleolytic activity is
stimulated by Ca21 and/or Mg21, with a combination of
the two being optimal for cyclophilins A and B. Mg21
alone is sufficient for cyclophilin C nuclease activity. pH
optimums are in the range of pH 7.5–9.5. Cyclophilins
can degrade both single-stranded and double-stranded
DNA. Additionally, cyclophilins produce 3*-OH termini
in linear double-stranded substrates, suggesting the
cuts produced are similar to those of apoptotic cells.
Cyclophilins also display endonucleolytic activity, dem-
onstrated by their ability to degrade supercoiled DNA.
In the absence of ions, cyclophilins bind linearized DNA.
When added to nuclei from nonapoptotic cells, cyclophi-
lin C induces 50-kilobase pair DNA fragmentation but
not internucleosomal fragmentation. Together, these
data suggest that cyclophilins are involved in degrada-
tion of the genome during apoptosis.
Cyclophilins (Cyps)1 comprise a highly conserved, ubiquitous
family of proteins first identified as the intracellular receptors
for the immunosuppressant drug cyclosporin A (CsA) (1). Cyps
range in size from 15 to 40 kDa (1–3). This large family of
proteins has been isolated from a diverse range of organisms,
including Neurospora (4), Escherichia coli (5, 6), yeast (7),
plants, and higher eukaryotes (7, 8). Cyps have been identified
in every tissue studied in humans (7, 8) and have been localized
to the cytoplasm (1), mitochondria (9), nucleus (8, 10), and
endoplasmic reticulum (11) in various mammalian cells and
the cytoplasm and periplasm (5, 12) in E. coli. Three well
characterized Cyps, CypA (18 kDa) (1, 13), CypB (21 kDa) (11),
and CypC (22.8 kDa) (14), are studied and discussed in this
paper. The widespread nature of Cyps suggests they may play
an important role in cellular metabolism.
Cyps have been shown to act as peptidylprolyl cis-trans-
isomerases whose activity can be blocked by CsA. As isomer-
ases, Cyps have been proposed to aid in protein folding. The
folding rates of human carbonic anhydrase II (15), RNase T1,
(16), and collagen (17) have been shown to be increased by Cyp
in vitro. However, whether this isomerase activity is physiolog-
ically significant is still not clear. Cyps have also been proposed
to act as chaperones (18, 19), chemotactic agents (20), or stress
response proteins (21, 22). Additionally, CypA has been shown
to bind to the p55 Gag protein of human immunodeficiency
virus (23) and appears to be necessary for successful human
immunodeficiency virus infection (24, 25).
Cyps also play a role in the immune system by binding to the
immunosuppressant drug CsA, although the exact nature of
this role is also unclear. When the CypzCsA complex is formed,
it can bind to and inhibit calcineurin (protein phosphatase 2B)
(26). The inhibition of calcineurin activity causes a decrease in
the nuclear levels of the transcription factor NF-AT, preventing
expression of the cytokine interleukin-2 and immune cell
activation (27, 28).
We recently reported a novel nuclease activity associated
with the Cyp proteins (29). The notion that Cyps might have
nucleolytic capabilities was suggested by a surprising sequence
and structural similarity between NUC18 (an 18-kDa nuclease
isolated from apoptotic rat thymocytes) and the Cyp family of
proteins. Apoptosis, or programmed cell death, is a type of cell
death that is highly ordered and follows a series of distinct
steps that eventually lead to the non-immune-responsive death
of the cell. One characteristic of apoptosis is the specific deg-
radation of the cell’s nucleic acids. There are two DNA frag-
mentation patterns observed in apoptosis; one involves the
production of fragments of DNA that are 180–200 base pairs in
length (or multiples thereof), and the other involves the pro-
duction of larger DNA fragments that are approximately 50 kb
in length (30, 31). While the characteristics of these apoptotic
nuclease activities have been extensively described (32–35), the
actual enzymes responsible have not been identified.
In this manuscript, we have evaluated and characterized the
nuclease activity of Cyps under native conditions and assessed
their potential role in apoptosis. We demonstrate that the
nuclease activity from Cyps under native conditions is distinct
from the isomerase activity and that there are many similari-
ties between the characteristics of nuclease activity from puri-
fied Cyps and those reported for apoptotic nuclease activity. In
addition, CypC is shown to produce 50-kb fragments in chro-
matin, further suggesting a nucleolytic role for Cyps in
apoptosis.
EXPERIMENTAL PROCEDURES
Materials—Purified recombinant CypA, -B, and -C were generously
provided by Sandoz Laboratories in Basel, Switzerland (36). They re-
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veal no contaminants according to the limits of the silver stain analysis
of SDS-polyacrylamide gels (29). The sources for other materials and
enzymes are provided throughout.
Thymocyte Preparation—Thymocytes were prepared from thymi iso-
lated from adrenalectomized male Sprague Dawley rats. Control thy-
mocytes were isolated from untreated rats, and apoptotic thymocytes
were prepared from thymi removed at different times following injec-
tion of the rat with 5 mg/kg of body weight dexamethasone (Steraloids).
After removal from the rat, the thymus gland was placed into ice-cold
phosphate-buffered saline, cut into small pieces, and homogenized with
10–15 passes of a loose-fitting Dounce homogenizer. The sample was
then poured through a Nitex mesh filter, and the cells were collected by
centrifugation at 4 °C (5 min, 4,000 rpm). The cells were resuspended in
fresh phosphate-buffered saline and passed through another Nitesh
mesh filter. After a second centrifugation, the cells were resuspended in
5 ml of phosphate-buffered saline and counted with a Coulter counter.
1 3 108 cells were removed and spun down in a microcentrifuge tube.
Resuspension of the cells in 200 ml of 10 mM MgCl2, 0.25% Nonidet P-40
buffer caused lysis of the plasma membrane and release of the nuclei.
The cells were incubated in this solution for 5 min on ice, and then the
nuclei were centrifuged out of solution (5 min, 4,000 rpm). The cyto-
plasmic supernatant was transferred to a clean tube, and the nuclei
were resuspended in an equal volume of the MgCl2/Nonidet P-40 solu-
tion. The extracts were prepared by the addition of an equal volume of
a loading buffer containing SDS and boiled 5 min.
Western Blot Analyses—Equal volumes of the cytoplasmic and nu-
clear preparation of control and apoptotic thymocytes were electro-
phoresed through a 15% SDS-polyacrylamide gel. The proteins were
transferred to nitrocellulose (BA-85) in a TBE (89 mM Tris, 89 mM boric
acid, 2.5 mM EDTA)/methanol buffer over 2 h at 80 V. Protein was
detected following the ECL (Amersham Corp.) detection procedure.
Antibodies directed against purified recombinant CypA were prepared
in rabbits and purified according to the protocol of Weigel et al. (37)
using the purified recombinant CypA affinity column.
Preparation of Substrate DNA—HB101 cells (Life Technologies, Inc.)
containing pUC18 plasmid (2690 base pairs) were grown at 37 °C in
Luria broth to an OD of 0.8 at 595 nm. Chloramphenicol was added to
a final concentration of 170 mg/liter, and incubation was continued
overnight. The cells were harvested, and the plasmid was purified via
standard cesium chloride gradient techniques. Plasmid DNA was lin-
earized (where stated) with the restriction endonuclease SmaI or XbaI
(New England Biolabs). Single-stranded DNA was prepared by boiling
the double-stranded DNA and immediately cooling on ice.
Solution Nuclease Assay—The solution nuclease assay was used to
determine optimal digestion conditions and enzyme kinetics. CypA, -B,
or -C was incubated with a nucleic acid substrate (supercoiled plasmid,
linear double-stranded DNA, and linear single-stranded DNA) at 37 °C
in a 20 mM Tris solution with appropriate ions and pH, as described in
Table I. In general, 1 mg of Cyp and 1 mg of DNA (linearized pUC18)
were combined in a total volume of 10 ml, resulting in a final concen-
tration of 5.6 mM CypA, 4.8 mM CypB, 4.4 mM CypC, and 56 nM pUC18
(30 mM phosphodiester bonds); any differences are noted in the figure
legends. A combination of 1 mM CaCl2 and 1 mMMgCl2 was used for the
kinetic assays. After incubation, loading buffer was added, and the
samples were heated to 65 °C for 10 min. The DNA was electrophoresed
through a 1% agarose gel and visualized by ethidium bromide staining.
Quantitation of Nucleic Acid Degradation—Densitometry was used
to quantitate the percentage of DNA degraded. Pictures of the ethidium
bromide-stained gels were scanned into a PowerMacIntosh (8100/80)
and then quantitated with the Image 1.56 ppc program (National In-
stitutes of Health). The amount of DNA used in each assay and the time
of exposure of the film were designed to ensure a densitometry reading
that was linear with respect to the concentration of the DNA. A two-step
process was used to calculate the percentage of DNA degraded at a
specific time point. First, the area under the peak corresponding to the
degraded DNA (less than 2690 base pairs) was divided by the area
under the peak corresponding to the total amount of DNA in the sample
and then this figure was multiplied by 100. For the relative efficacy of
the activating ions, the amount of degraded DNA minus background
was determined, and the percentage of DNA degraded relative to the
Ca21/Mg21 sample was calculated. For the relative rate of DNA degra-
dation, the amount of DNA degraded at a specific time was determined
for each Cyp as well as micrococcal nuclease. This amount was then
divided by the time of degradation (in minutes) and the molarity of each
enzyme so that the percentage degraded/min/mol of enzyme was deter-
mined. The amount of degradation of linear double-stranded pUC18/
min/mol of CypA, -B, and -C relative to the amount degraded/min/mol of
micrococcal nuclease was calculated.
End Labeling Degraded DNA—After incubation with Cyp, the DNA
was purified by phenol/chloroform/isoamyl alcohol (25:24:1) extractions
followed by chloroform/isoamyl alcohol (24:1) alone. 10 units of terminal
deoxynucleotidyltransferase (Life Technologies, Inc.) and 750,000 cpm
of [32P]dCTP (ICN) were added to the DNA and incubated for 2 h at
37 °C. Labeled DNA was isolated by centrifugation through a Sephadex
G-50 (Sigma) column and was then electrophoresed through a 1%
agarose gel. The gel was dried and then exposed to autoradiographic
film for visualization.
Gel Shift Assays—The substrate DNA was an 18-mer oligonucleotide
(CGACCAGAGTACGTGATG) that was end-labeled with terminal de-
oxynucleotidyltransferase (Life Technologies, Inc.) and [32P]dCTP. Af-
ter incubating the DNA in the labeling reaction for 0.5 h at 37 °C, the
reaction was stopped with 2 ml of 10 mM EDTA and brought to 100 ml
with double-distilled H2O. The labeled DNA was separated from unin-
corporated nucleotides by a Sephadex G-25 (Sigma) spin column. The
resulting labeled DNA was then diluted to 20,000 cpm/ml. 1 ml of this
DNA was incubated in the absence or presence of 1 mg of CypB in a
binding buffer (20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 5% glycerol) for
16 h at 4 °C. The samples were then electrophoresed through a 6%
polyacrylamide gel, the gels were dried, and the samples were visual-
ized by exposure to XAR film (Kodak).
Electron Microscopy—Electron microscopy was performed as de-
scribed previously (38). Briefly, the CypB/DNA samples were prepared
by incubation of 1 mg of CypB with 1 mg of linearized plasmid DNA in
the absence of ions. The samples were fixed with 0.6% glutaraldehyde
and then passed through a BioGel A5 m (Bio-Rad) column to remove
unbound proteins. The samples were mounted onto charged carbon-
coated grids and dehydrated through a series of graded alcohol rinses,
with a final wash of 100% alcohol. The grids were then shadowed with
tungsten and examined by transmission electron microscopy.
Peptidylprolyl Isomerase Assay—The cis-trans-peptidylprolyl iso-
merase assay was performed as described previously (39). 50 mM n-
succinyl-Ala-Ala-Pro-Phe p-nitroanilide was added to 35 mM Tris-HCl
(pH 8) in a total volume of 1 ml at 10 °C. 1 mg of Cyp and 50 ml of 100
mM chymotrypsin were quickly added to the substrate and mixed. The
chymotrypsin can cleave the p-nitroanilide substrate only when the
proline residue is in the trans configuration. Once cleaved, the sub-
strate produces a yellow color that can be quantitated by its absorbance
at 390 nm (OD 390). The increase in optical density over time is
indicative of the number of proline residues converted to trans over
time. The OD 390 is read every 0.3 s for 3 s on a Beckman DU 640
spectrophotometer. The slope of OD versus time is the rate of conver-
sion, and the average of at least three separate assays is shown for each
given condition.
Chromatin Degradation Assay—The HeLa nuclei assay was per-
formed as described previously (40).2 Briefly, HeLa cells were grown in
suspension culture (1–7 3 105 cells/ml) at 37 °C in Joklik’s minimum
essential medium supplemented with 2% fetal calf serum, 2% calf
serum, 2 mM glutamine, 75 units/ml penicillin and 50 units/ml strep-
tomycin sulfate. HeLa nuclei were prepared by pelleting the cells and
resuspending in 10 mM MgCl2, 0.25% Nonidet P-40. The nuclei were
then pelleted and resuspended in 50 mM Tris (pH 7.4). Aliquots (2 3 106
nuclei) were then added to tubes containing 50 mM Tris (pH 7.4), 2 mM
MgCl2, 1 mM CaCl2 (final concentrations in a total volume of 400 ml) in
the presence or absence of 500 nM CypC. Samples were incubated for 5 h
at room temperature with gentle rotation. Studies in our laboratory
have shown that HeLa nuclei incubated under these conditions undergo
very little spontaneous chromatin degradation (41).
For pulsed field analysis, 200 ml was removed at the end of the
incubation, mixed with an equal volume of 1% Incert agarose (FMC
Bioproducts) at 37 °C, transferred to a 0.5-cm2 mold, and placed at 4 °C
for 5 min to solidify. Plugs were then incubated in 100 mM EDTA, 1%
(w/v) N-lauroylsarcosine (10 ml) at 37 °C overnight before being trans-
ferred to 1 ml of the same buffer containing proteinase K (100 mg) and
reincubated for a minimum of 16 h at 50 °C. Plugs were stored at 4 °C
in this buffer until used. A 2.0-mm-thick slice of the agarose plug was
equilibrated in 50 ml of 0.5 3 TBE buffer for .3 h before being incor-
porated into a 1% agarose gel. The gel was placed in a clamped homo-
geneous electric field pulsed field system (Bio-Rad) filled with 0.5 3
TBE and allowed to equilibrate to 14 °C before electrophoresis for 19 h
at 6.0 V/cm with a linear switch interval ramp from 0.5 to 45.0 s. The
parameters were chosen to optimally separate DNA fragments ranging
from 10 to 500 kb (42)3 The gel was then stained with ethidium bromide
2 Hughes, F., and Cidlowski, J. (1997) Cell Death Diff., in press.
3 E. Lai, personal communication.
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and visualized by UV transillumination.
Following removal of the aliquot for pulsed field analysis, conven-
tional electrophoresis samples were prepared from the remaining nuclei
by first adding EDTA, NaCl, and sodium dodecyl sulfate to a final
concentration of 25 mM, 540 mM, and 0.5%, respectively. TE buffer (10
mM Tris, pH 7.4, 1 mM EDTA) was added to bring the final volume to
400 ml, and Proteinase K was added to 0.5 mg/ml. Samples were then
incubated for 1 h at 50 °C and extracted twice with phenol/chloroform/
isoamyl alcohol (25:24:1) and once with chloroform/isoamyl alcohol
(24:1) alone. DNA was precipitated by adding 10 ml of 5 M NaCl plus 1
ml of ice-cold 100% ethanol and incubating at 270 °C for at least 20
min. DNA was collected by centrifugation, dried, and resuspended by
incubating the pellet overnight at 37 °C in TE buffer containing 0.33
mg/ml DNase-free RNase A. DNA concentrations were determined
spectrophotometrically, and samples (15 mg) were then electrophoresed
(3.25 h; 80 V) on a 1.8% agarose gel submerged in 0.5 3 TPE (40 mM
Tris-phosphate, 4 mM EDTA). Gels were subsequently stained with
ethidium bromide and visualized by UV transillumination.
RESULTS
Recombinant CypA, -B, and -C Degrade DNA under Nonde-
naturing Conditions—Previously, we used a radioactive gel
nuclease assay to demonstrate that three members of the Cyp
family, CypA, -B, and -C, are able to degrade DNA (29); how-
ever, this assay used a protein denaturation and renaturation
step prior to analysis of nuclease activity, and thus it was
unclear if native Cyps have the same nucleolytic activity. To
determine whether the native Cyps could degrade DNA, we
employed a solution nuclease assay that evaluates the nuclease
activity from the nondenatured recombinant protein. In this
assay, the purified Cyp is incubated with linearized plasmid
(pUC18) in the presence of 1 mM Ca21 and 1 mM Mg21. The
production of low molecular weight DNA indicates an active
nuclease in that sample. The results of the solution nuclease
assay with purified CypA, -B, and -C are shown in Fig. 1.
Samples with DNA only, in the absence or presence of ions (Fig.
1A, Con panel, 1EDTA, 1Ca21/Mg21 lanes, respectively) do
not contain detectable levels of degraded DNA. CypA and CypB
show greater DNA degradation in the presence of Ca21 and
Mg21 than in the absence of these ions (Fig. 1A, CypA and
CypB panels), whereas CypC can also degrade substantial lev-
els of DNA in the absence of any additional ions (Fig. 1A, CypC
panel,1EDTA lane). The nuclease activity of CypC is, however,
enhanced by the addition of the divalent cations (Fig. 1A, CypC
panel, 1Ca21/Mg21 lane). Similarly, single-stranded DNA is
best degraded by CypA and CypB in the presence of Ca21 and
Mg21 and by Cyp C in either the absence or the presence of
these ions (Fig. 1B). Together, these data demonstrate a nu-
cleolytic action on different forms of DNA by native Cyps.
Determination of Optimal Conditions for Cyp Nuclease Ac-
tivity—To obtain the ideal conditions for each Cyp’s nuclease
activity and to be able to compare Cyp nuclease activity with
that of other apoptotic nucleases, we determined the optimal
pH and ion requirements of CypA, -B, and -C in vitro. The
optimal pH for each Cyp was determined by performing a series
of solution nuclease assays over a pH range from 5.5 to 10.0,
with increments of 0.5 pH units. As shown in Fig. 2, CypA, -B,
and -C can degrade the linearized plasmid substrate over the
range of pH values, with the maximum activity seen from pH
7.5 to pH 9.5. Quantitation of these assays (data not shown)
revealed that each Cyp had a slightly different pH optimum,
with CypA being most efficient at pH 8.0, CypB at pH 8.5, and
CypC at pH 9.5.
Cation Dependence—Many of the nucleases proposed to be
involved in apoptosis have been shown to be dependent on Ca21
and/or Mg21 for activation (32, 34, 43, 44); therefore, we were
interested in determining how these two cations affected nu-
clease activity derived from Cyps. As shown in Fig. 1, some
degradation occurs in the absence of added ions, especially with
CypC; however, further experimentation with a series of solu-
tion nuclease assays performed at increasing Ca21 and Mg21
concentrations revealed that optimal degradation by each Cyp
occurred at 1 mM of either ion (data not shown). The amount of
DNA degraded in the presence of either ion alone was deter-
mined as the percentage degraded relative to the amount de-
graded in the presence of 1 mM Ca21 and Mg21. These results
are shown in Table I. CypA and CypB had optimal nuclease
activity with a combination of Ca21 and Mg21, whereas CypC
was most active in the presence of Mg21 alone. Under all
circumstances, CypC displayed the greatest efficiency at DNA
degradation, with a 100 times greater DNA degrading activity
than CypA or CypB under the same experimental conditions
(data not shown). Interestingly, this difference in activity was
not appreciated in the previous experiments performed under
denaturing conditions (29) and probably reflects an inefficient
renaturation of CypC, the highest molecular weight protein of
FIG. 1. Cyclophilins A, B and C degrade linear double-
stranded DNA and linear single-stranded DNA in a nondenatur-
ing solution nuclease assay. Panel A contains samples with double-
stranded DNA, and panel B contains samples with single-stranded
DNA. Each lane contains 1 mg linearized pUC18 (3 nmol of phosphodi-
ester bonds) as substrate in either the double- or single-stranded form,
prepared as described under “Experimental Procedures,” plus 1 mM
each CaCl2 and MgCl2 brought up to a final volume of 10 ml with 20 mM
Tris, pH 8.0. CypA, -B, and -C are 5.6, 4.8, and 4.4 mM, respectively. The
left lane in each set has only ions and DNA present in Tris buffer. The
presence of low molecular weight DNA (i.e. strands that are smaller
than the 2690-base pair substrate) indicate the presence of an active
nuclease in that sample. Low molecular weight DNA is generated by
CypA, -B, and -C with both a single-stranded and a double-stranded
linear DNA substrate.
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the three studied. These optimal conditions were applied to
further characterizations of the nuclease activity and the in-
teraction of Cyps with DNA.
Cyps Have Endonucleolytic Activity—Substitution of super-
coiled DNA for linear DNA as substrate in the solution nucle-
ase assay allows for discrimination of Cyp endo- or exonuclease
activity. The addition of supercoiled plasmid to the digestion
assays revealed that it could be cleaved by CypA, -B, and -C
(Fig. 3), indicating that each pure protein had endonucleolytic
activity. Interestingly, both nicking and linearizing activities
were observed in both the presence and absence of added ions.
CypA and CypB, which degrade at a slower rate than CypC,
clearly demonstrate a nicking activity by the conversion of the
supercoiled substrate (SC) to both open circular (OC) and lin-
ear (L) forms prior to degradation to lower molecular weight
forms (Fig. 3, CypA, 1Ca11/Mg11 lane, and CypB, 1Ca
11
/
Mg11 lane). CypC shows only a conversion to low molecular




CypB Binds to DNA in the Absence of Ca21 and Mg21—To
explore the interaction between Cyps and DNA more directly,
we took advantage of the different efficiencies of DNA degra-
dation by the different Cyps. While CypC demonstrates a clear
nucleolytic activity in the absence of added ions, CypA and
CypB show much lower levels of DNA degradation in the ab-
sence of ions. Thus, by incubating CypA and CypB with DNA in
the absence of added ions, we were able to observe a direct
interaction between protein and the DNA substrate. Several
different approaches were employed, including gel shift assays
and electron microscopy, which allowed for a clear picture of
Cyp/DNA interaction. Fig. 4A shows a gel shift assay with
CypB and radiolabeled linear pUC18 as a substrate. The CypB
lane shows a band of slower migrating DNA, indicating that it
is bound to the protein. Electron micrographs of linear pUC18
and CypB incubated in a similar manner, i.e. without added
ions, reveal CypB bound at discrete sites along the DNA strand
(Fig. 4B). These are the first such images to show direct inter-
action between CypB and linear DNA. The stochastic arrange-
ment of the CypB multimers along the DNA substrate suggests
that some specificity may be involved in Cyp binding to DNA.
Inhibitors of Cyp Nuclease Activity—An important property
of a nuclease is its ability to be regulated in vivo. There are
several agents, such as zinc (45) and aurintricarboxylic acid
(46), that are well known inhibitors of both apoptosis and
nucleases. We have previously shown that these two agents are
capable of inhibiting Cyp nuclease activity in the radioactive
gel assay at 2 and 1 mM, respectively (29). In the solution
TABLE I
Calcium and magnesium ion activation of
cyclophilin nuclease activity
The amount of DNA degraded by cyclophilins A, B, and C in the
presence of 1 mM Ca21 alone or 1 mM Mg21 alone was compared as a
percentage of the amount of DNA degraded in the presence of 1 mM both
Ca21 and Mg21. The assays and quantitation procedures were per-
formed as described under “Experimental Procedures.”
Reaction conditions CypA CypB CypC
1 mM Ca21/Mg21 100% 100% 100%
1 mM Ca21 61.8 80.2 70.8
1 mM Mg21 45.5 42.4 184.8
FIG. 3. Cyclophilins demonstrate an endonucleolytic activity
by degrading supercoiled plasmid. 1 mg of supercoiled pCTF1 plas-
mid (3 nmol of phosphodiester bonds) was incubated with 40 pmol of
CypA, 40 pmol of CypB, or 20 pmol of CypC for 3 h at 37 °C in the
absence (2) and presence (1) of 1 mM Ca21/Mg21. Cleavage occurred in
the samples containing Cyps and ions, and some nicking activity is
apparent in the CypC, 2Ca11/Mg11 sample. CypA and CypB demon-
strate a nicking activity in the presence of ions by converting the
supercoiled (SC) form to open circular (OC) and linear (L) forms. CypC
produces low molecular weight fragments in the same time period. The
cleavage of supercoiled DNA by the Cyps indicates an endonucleolytic
capacity.
FIG. 2. pH dependence of cyclophilin nuclease activity. The
solution nuclease assays were performed with a double-stranded lin-
earized pUC18 plasmid substrate as described in the legend to Fig. 1,
with the exception that buffers of differing pH values were substituted
in place of the 20 mM Tris, pH 8.0, buffer. The buffers were all 20 mM
and included MES (pH 5.5 and 6.0), HEPES (pH 6.5, 7.0, and 7.5), Tris
(pH 8.0 and 8.5), and CAPS (pH 9.5 and 10.0). The amount of DNA
degraded in each case was measured densitometrically, and the results
from three separate experiments for each Cyp revealed optimal pH
values to be pH 8.0 for CypA, pH 8.5 for CypB, and pH 9.5 for CypC.
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nuclease assay, 100 mM zinc completely blocked DNA degrada-
tion by each Cyp (data not shown). However, we were inter-
ested in determining whether more physiologically relevant
factors, such as certain common ions, could also attenuate Cyp
nuclease activity. We chose to examine the effects of K1 and
Na1 on Cyp nuclease activity because ion fluxes have recently
been shown to be involved in apoptosis (47, 48). When either
K1 or Na1 was added to a solution nuclease assay containing 1
mM Ca21 and Mg21, there was a dose-dependent decrease in
the amount of DNA degraded, with IC50 values at approxi-
mately 79 mM K1 and 48 mM Na1 (Table II). Lower concentra-
tions of each ion resulted in partial inhibition of nuclease
activity from Cyps in a dose-dependent manner. The effect of a
specific Cyp-binding agent was then assessed for its ability to
inhibit or enhance Cyp nuclease activity.
CsA Does Not Inhibit Cyp Nuclease Activity—The binding of
the immunosuppressant drug CsA to Cyp is known to inhibit
the peptidylprolyl isomerase activity of Cyps (16, 49). We also
observe CsA inhibition of peptidylprolyl isomerase activity. As
shown in Fig. 5A, when the Cyp is incubated at a 1:1 molar
ratio with CsA for 15 min prior to being added to the assay
reaction, there is a complete inhibition of the Cyp isomerase
activity (see “Experimental Procedures”). However, when CsA
is added to the solution nuclease assay, we do not observe any
change in the DNA degradation profile (Fig. 5B). These results
demonstrate that the Cyps we were evaluating for nuclease
activity have isomerase activity and, further, that these Cyps
are capable of binding to CsA with a well characterized re-
sponse. In addition, these data show for the first time that the
nuclease activity of Cyps is separate from the isomerase
activity.
Cyp Is Located in the Nucleus of Control and Apoptotic Thy-
mocytes—While our previous work demonstrated a surprising
homology between NUC18, a nuclease isolated from apoptotic
rat thymocyte nuclei, and Cyp proteins (29), it was not clear
whether Cyps were nuclear proteins in rat thymocytes. To
address this question, we developed antibodies directed against
Cyp proteins. Western blot analyses of nuclear and cytoplasmic
extracts from rat thymocytes could then be performed. The
results (Fig. 6) showed an 18-kDa band that reacts to these
antibodies, revealing that Cyp is located in both the nucleus
and the cytoplasm of rat thymocytes. Additionally, we were
also interested in determining whether Cyp levels in either
compartment were altered following stimulation of apoptosis.
Nuclear and cytoplasmic extracts were prepared from thymo-
cytes isolated at increasing time points following dexametha-
sone treatment of rats (0–4 h) and analyzed by Western blot-
ting. These results indicated that there were no changes in Cyp
levels in either the nucleus or cytoplasm during the early
stages of apoptosis. The Western blot for the 4-h time point is
also shown in Fig. 6. Thus, we observed that Cyps are located
in the nucleus as well as the cytoplasm of rat thymocytes and
that the levels of the protein are unchanged during dexametha-
sone-induced apoptosis.
Cyps Produce 39-OH Termini—After characterizing a variety
of aspects of nuclease activity from Cyps to compare with
apoptotic nucleases, we next wanted to determine what type of
termini was produced in the Cyp-fragmented DNA, because
apoptotic DNA fragmentation is associated with the formation
of 39-OH termini (50). Terminal deoxynucleotidyltransferase
specifically attaches free nucleotides to 39-OH termini of DNA,
so we could determine if Cyps caused the formation of free
39-OH groups by attempting to label Cyp-cleaved DNA prod-
ucts with terminal deoxynucleotidyltransferase and
[32P]dCTP. These assays revealed an increase in the number of
39-OH termini in the digested versus the control samples (Fig.
FIG. 4. CypB interaction with linearized DNA. A, cyclophilin B shifts DNA migration in a nondenaturing gel. The gel shift assay was
performed as described under “Experimental Procedures.” The left lane contains labeled oligonucleotides, and the right two lanes are duplicate
samples of the oligonucleotide incubated with CypB. The slower migrating band in these two samples demonstrates binding of CypB to DNA. B,
electron microscopy reveals that CypB binds at discrete sites along linear pUC18. 2 mg of (4.8 mM) CypB were incubated with 2.7 mg of (56 nM) linear
pUC18 in 20 mM Tris-HCl (pH 7.5) without ions for 2 h prior to fixing and preparing for electron microscopy. These electron micrographs show
multimers of CypB binding at certain sites along the DNA strand. The discrete binding of CypB suggests that Cyps have preferred binding sites
along the strand of DNA.
TABLE II
IC50 of potassium and sodium ions on cyclophilin nuclease activity
NaCl and KCl were added at increasing concentrations to the solution
nuclease assay, which also contained 1 mM Ca21 and Mg21. The IC50 for
Na1 and K1 were determined by quantitating the amount of DNA
degraded in the presence of each ion at 0, 1, 10, and 100 or 150 mM,
depending on the ion. Na1 showed complete inhibition at 100 mM and
K1 at 150 mM. The percentage of DNA degraded was plotted as a
function of the concentration of the inhibitory ion. The concentration of
ion at 50% degradation was then determined from the slope of that line.




CypA 82.6 6 6.8 44.1 6 3.6
CypB 76.3 6 8.8 51.6 6 0.6
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7; cf. Control lane with CypA and CypB lanes). The DNA di-
gested with micrococcal nuclease, which produces termini with
39-phosphate groups does not label with terminal deoxynucle-
otidyltransferase (Fig. 7, MN lane). With the generation of
39-OH termini, Cyps exhibit a similarity with the nuclease (or
nucleases) activated during apoptosis.
CypC Generates 50-kb DNA Fragments in Chromatin—With
the solution nuclease assay, we have been able to show that
many aspects of Cyp nuclease activity are similar to that of
apoptotic nucleases. To further explore the notion that Cyps
may be nucleolytically active during apoptosis, we investigated
the most active Cyp, CypC, for its ability to digest chromatin
DNA in the HeLa nuclei assay. Because there are two different
types of DNA degradation observed during apoptosis (50-kb
fragments and smaller, internucleosomally cleaved fragments
(51)), we looked for both DNA degradation patterns in HeLa
DNA following incubation with CypC. As shown in Fig. 8, the
addition of CypC to HeLa nuclei in the presence of Ca21 and
Mg21 completely eliminated the high molecular weight chro-
matin (panel B), as shown by loss of DNA in the well and the
compression band. The addition of CypC also generated a 50-kb
band of DNA from the HeLa chromatin. Additionally, an in-
crease in low molecular weight DNA is observed (panel A),
although internucleosomal degradation patterns were not ob-
served. This assay demonstrates that CypC is capable of acting
FIG. 7. Cyclophilins produce 3*-OH termini in linear double-
stranded DNA. Following incubation with either no protein, cyclophi-
lin A (CypA), cyclophilin B (CypB), or micrococcal nuclease (MN), DNA
was labeled with terminal deoxynucleotidyltransferase and [32P]dCTP.
The lower panel (EtBr Stained DNA) shows the DNA after electrophore-
sis through a 1% agarose gel. Because of the purification step prior to
running the gel, much of the degraded, low molecular weight fragments
were lost. After the gel was dried and exposed to film, the remaining low
molecular weight DNA from the cyclophilin-degraded samples were
readily apparent. The increase in the amount of end labeling in these
samples as compared with the untreated sample (Control lane) or
MN-treated sample (MN lane), which produces 39-PO4 termini, indi-
cates an increase in the production of 39-OH ends by the Cyps.
FIG. 5. Cyclosporin A does not inhibit Cyp nuclease activity. A,
the results of the peptidylprolyl isomerase assays (described under
“Experimental Procedures”) with CypA and CypB. When CsA is added
to the isomerase assays at a 1:1 molar ratio with the Cyp, there is a
decrease in the rate of conversion from cis to trans in the substrate.
Taken together, these data indicate that the nuclease activity of Cyps is
separate from its isomerase activity. B, a series of solution nuclease
assays were performed in the presence of no protein, CypA (202 pmol),
CypB (48 pmol), and CypC (10 pmol), with DNA alone (14 nmol of
phosphodiester bonds); DNA plus 1 mM Ca21/Mg21; or DNA, ions, and
CsA (CsA was at a 1:1 molar ratio with the Cyp in each sample). These
data show that the addition of CsA does not alter the amount of Cyp
DNA degradation.
FIG. 6. Cyclophilin is located in the nucleus and the cytoplasm
of nonapoptotic and apoptotic thymocytes. Western blot analyses
of rat thymocyte extracts from nonapoptotic (Control) and apoptotic
(Dex) nuclear and cytoplasmic extracts are shown. The thymocyte ex-
tracts from adrenalectomized rats that were either untreated or in-
jected with dexamethasone 4 h prior to preparation were harvested,
fractionated, and assayed as described under “Experimental Proce-
dures.” Affinity-purified anti-CypA antibodies recognized an 18-kDa
protein in the nucleus and cytoplasm of apoptotic and nonapoptotic
thymocytes, demonstrating that Cyps are located in both the nucleus
and the cytoplasm. The “CypA” lane contains 2 mg of purified recombi-
nant CypA.
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on chromatin DNA and generating a 50-kb product, similar to
what is observed during apoptosis.
DISCUSSION
Cyps comprise a highly abundant family of proteins (1) that
are expressed in every organism studied to date. They possess
peptidylprolyl cis-trans-isomerase activity (16, 49), and have
been shown to enhance the folding rate of several proteins in
vitro (15–17). We recently reported a sequence and structural
homology between Cyps and NUC18, an apoptotic nuclease,
and demonstrated that several members of the Cyp family have
an inherent nuclease activity (29). We have now further char-
acterized the nuclease activity of Cyp and demonstrated that it
is located in the nucleus and shares many characteristics with
nucleases associated with apoptosis.
Although there is still some debate as to the pH in apoptotic
cells, there are many reports of an apoptotic nuclease with a pH
optimum in the 7.5–9.5 range (32, 52–54), similar to that ob-
served for CypA, -B, and -C. These three Cyps display an
ion-dependent nuclease activity that can be activated by either
Ca21 or Mg21 or by a combination of both, although to different
efficiencies in each. This Ca21/Mg21 dependence correlates
with what has been observed for apoptotic nucleases in other
studies (32–35). Interestingly, we observe a much stronger
activation of CypC by Mg21 alone than by Mg21 plus Ca21. Sun
and Cohen (43) were recently able to distinguish two apoptotic
nuclease activities (50-kb fragmentation from internucleoso-
mal cleavage) by using Ca21 and Mg21 ions, such that the
addition of Mg21 alone to nuclei resulted in the digestion of
DNA into 50-kb fragments, while internucleosomal cleavage
was not observed until Ca21 was added in conjunction with the
Mg21. Thus, the strong activation of CypC by Mg21 alone, plus
the observation that CypC addition to isolated nuclei results in
the formation of 50-kb fragments of chromatin DNA, suggests
that CypC could be responsible for the cleavage of DNA into
50-kb fragments. We also observe inhibition of Ca21/Mg21-
stimulated nuclease activity at physiologically relevant levels
with the ions Na1 and K1. The normal intracellular concen-
tration of K1 is approximately 140 mM, a concentration high
enough to inhibit Cyp nuclease activity; however, the decrease
in the intracellular K1 concentration during the shrinkage of
cells undergoing apoptosis (47)4 results in conditions in which
Cyps become active nucleases. The inhibitory effect of Na1 at
concentrations that correspond to the higher levels observed in
necrotic cells (55) suggests that Cyps would not act during
necrotic cell death. Thus, these two facts together imply that
Cyps can act as apoptotic-specific nucleases. An important
finding first discovered in our study is the production of 39-OH
termini by Cyp, which corresponds to what has been observed
in many cases of apoptosis (50). In fact, the terminal de-
oxynucleotidyltransferase-mediated dUTP-biotin nick end la-
beling (TUNEL) method, a technique widely used to detect
apoptotic cells in situ (50), is based on the overproduction of
39-OH ends in apoptotic cells. Thus, these data demonstrate
that the characteristics of Cyp nuclease activity are suggestive
of an apoptotic nuclease.
Because the catalytic activity most associated with Cyps is
peptidyl-prolyl isomerization, we were interested in determin-
ing whether the novel nuclease activity of Cyps was related to
the isomerase activity. The addition of the high affinity ligand
CsA to the solution nuclease assay did not affect the ability of
Cyps to degrade DNA, whereas it completely blocked the
isomerase activity. These results indicate that the nuclease
and isomerase properties of Cyps are distinct.
Although the rate of isomerization by the Cyps in in vitro
assays shows a high efficiency (56), Cyps degrade DNA at a
lower rate compared with the well characterized micrococcal
nuclease. This highly efficient enzyme (which has a turnover
rate of 95 s21; Ref. 57) degrades DNA approximately 1000
times faster than CypC. CypC, in turn, displays a nuclease
activity approximately 100 times greater than CypA and CypB.
There are several potential reasons for this apparently slower
rate of Cyp nuclease activity. The first is that the proteins used
in these assays are recombinant forms and therefore may be
missing an essential post-translational modification that en-
hances their nucleolytic activity. Another possibility is that
complete activation of the Cyps requires a co-factor or addi-
tional protein that was absent from our solution nuclease as-
says. We have shown that multimers of CypB bind to a strand
of DNA with some specificity. It may be that an additional
protein will enhance the DNA binding and nucleolytic activities
of Cyp. Indeed, Cyp binds only weakly to calcineurin by itself,
but it shows great affinity for calcineurin with the addition of
CsA (58). Thus, there are several possibilities to account for the
rate of DNA degradation by Cyps. Nevertheless, it was impor-
tant for us to determine if the nuclease activity of Cyps was
sufficient to account for the levels of DNA degradation observed
during apoptosis in vivo. To completely convert chromatin,
which contains 6 3 109 nucleotides (59), to 50-kb fragments,
60,000 phosphodiester bonds must be cleaved. Human thymo-
cytes contain approximately 540,000 molecules of CypA (based
on an average of 1.6 mg of CypA/mg of cell protein) (8). There-
fore, only 60,000, or 11%, of all CypA molecules in the thymo-
cyte need to be in contact with the chromatin and to make one
disruption of the phosphodiester bond to completely reduce the
chromatin to 50-kb fragments. Thus, the number of CypA mol-
ecules is more than adequate to at least account for the com-
plete degradation of the genome to 50-kb fragments during
apoptosis.
How might Cyps become active as nucleases during apopto-
sis? We have already shown that the levels of the protein
4 C. Bortner and J. Cidlowski, unpublished observations.
FIG. 8. Cyclophilins generate 50-kb fragments in HeLa chro-
matin. 500 nM CypC were added to 2 3 106 HeLa nuclei in the presence
of Ca21 and Mg21 and incubated for 5 h at room temperature. After
incubation, the samples were analyzed for the production of both large
chromatin breaks as well as internucleosomal breaks, as described
under “Experimental Procedures.” The internucleosomal cleavage as-
say (A) reveals that lower molecular weight DNA is generated by the
addition of CypC to the HeLa nuclei; however, the “ladder pattern” of
internucleosomally cleaved DNA characteristic of apoptosis is not ap-
parent. The 50-kb fragments produced in the CypC-treated samples are
shown in B. The non-CypC-treated nuclei samples (Con) are shown to
the left in each panel and display some background chromatin cleavage
in both cases.
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remain unchanged during apoptosis; therefore, we propose sev-
eral potential activation mechanisms. The first potential acti-
vation mechanism involves the loss of K1 ions at the onset of
apoptosis. We have shown how the normal intracellular K1
levels are sufficient to prevent Cyp activity and that a decrease
in K1 levels allows Cyp nuclease activity to occur. Thus, atten-
uation of K1 levels in the nucleus may be all that is necessary
to activate Cyp nuclease activity. An additional possibility is
that the loss of K1 ions stimulates release of Cyp from an
inhibitory complex, freeing the active Cyp to act on the chro-
matin. In support of this idea, earlier work in our laboratory
revealed that NUC18 was associated with a high molecular
weight complex in nonapoptotic cells (60). Work performed in
other laboratories (61), has shown that Cyp is part of a large
multiprotein complex, which also suggests the possibility of an
inhibitory complex for Cyp under nonapoptotic conditions. An-
other possible mechanism for activation of Cyp nuclease activ-
ity is that Cyps may have altered post-translational modifica-
tion during apoptosis such that they are now capable of
degrading the chromatin DNA. Recently, Chatellard-Gruaz et
al. (62) demonstrated that isoforms of CypA were differentially
expressed during keratinocyte differentiation, a process with
many similarities to apoptosis. Additionally, Krummrei et al.
(41), who describe CypA as a Zn21-dependent DNA-binding
protein, suggest that CypA exists in two isoforms, one of which
involves Zn21-dependent DNA binding and the other involving
Zn21-independent isomerase and nucleolytic activity. Thus,
there are several potential mechanisms to explain how Cyp
might act as an apoptotic nuclease.
In summary, we have characterized several different aspects
of Cyp nuclease activity, all of which suggest that Cyps could be
apoptotic nucleases. For example, Cyps display a dependence
on Ca21 and Mg21 for optimal activity, and they produce 39-OH
termini in the digested DNA. They are also capable of degrad-
ing a variety of DNA substrates and can generate 50-kb frag-
ments in HeLa chromatin. We propose that Cyps are activated
to degrade chromatin during apoptosis. Further analysis of the
role of Cyp in apoptosis is ongoing.
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